Nugene Pharma (Shandong) is a subsidiary of Zhejiang Hengkang Pharmaceutical, specializing in the development, manufacturing, and marketing of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. Acquired from Meiji Pharma, the company is a leader in providing high-quality, innovative products across various sectors, including green synthetic biology and nucleic acid materials for global clients. With strong R&D capabilities and GMP-certified facilities, the company plays a crucial role in the pharmaceutical supply chain, offering products such as mRNA raw materials and nucleosides.